🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
* Determine whether VI-0521 has an effect on the electrical activity of the...
Status
Completed
Location
MDS Pharma Services
Start Date
2009-02
Trial ID
NCT00839891
Treatments Being Tested
This study is designed to determine the effects of a single dose of the stu...
Status
Completed
Location
Clinical Pharmacology of Miami
Start Date
2008-10
Trial ID
NCT00768209
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and efficac...
Status
Completed
Location
Kentucky Research Group
Start Date
2008-08
Trial ID
NCT00745251
The purposes of this study are to: * Find out how much of the study drugs ...
Status
Completed
Location
MDS Pharma Services
Start Date
2009-02
Trial ID
NCT00842400
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of vario...
Status
Completed
Location
Research Site
Start Date
2007-12
Trial ID
NCT00563368
Treatments Being Tested
The primary objective of this study is to describe the pharmacokinetic prof...
Status
Completed
Location
Research Facility
Start Date
2016-03
Trial ID
NCT02714062
Treatments Being Tested
This study is being conducted to assess weight loss efficacy, as determined...
Status
Completed
Location
Intend Research, LLC
Start Date
2019-05-02
Trial ID
NCT03922945
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of VI-0521...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00486291
VI-0521, a fixed dose combination of immediate-release (IR) phentermine and...
Status
Completed
Location
Advanced Clinical Research Institute
Start Date
2008-10
Trial ID
NCT00768404
Treatments Being Tested
The study is being conducted to evaluate the effect of VI-0521 (Qsymia®) on...
Status
Completed
Location
Clinical Site
Start Date
2022-01-25
Trial ID
NCT05215418
Treatments Being Tested